Company attributes
Other attributes
CytRx is a company operating in the pharmaceutical industry, focusing on healthcare, biomedical engineering, biopharmaceutical, RNA-based and RNA-targeted therapeutics, biology, biotechnology, and engineering . The company is headquartered in Los Angeles, United States , and is incorporated in Delaware . CytRx is listed on the Nasdaq exchange under the stock symbol CYTR .
The company was founded by H. Lee Herron and has been operating since 2002 . CytRx currently employs between 20 and 49 people . The company's CEO is Stephen Snowdy , and the CFO is John Y. Caloz . The former CEO of the company was Steven A Kriegsman .
CytRx has raised a total funding amount of $132,500,000 in venture rounds , with the latest funding round taking place in May 2018 . The company's investors include Hercules Technology Growth Capital Inc .
The company has been assigned 10 patents and operates with a B2C business model . CytRx's official website is http://cytrx.com , and they can be contacted via email at info@cytrx.com . The company's phone numbers are +13108265648 and +13108266289 . CytRx's full address is 11726 San Vicente Blvd. Suite 650 Los Angeles, California 90049 .
CytRx has a presence on social media platforms, including Twitter (https://twitter.com/cytr4f8ef8de84?lang=en) and LinkedIn (https://www.linkedin.com/company/cytrx-corporation) . The company's Crunchbase URL is https://www.crunchbase.com/organization/cytrx-corporation , and its Pitchbook URL is https://pitchbook.com/profiles/company/41240-53 . CytRx's Legal Entity Identifier can be found at https://search.gleif.org/#/record/549300XDBGI8PTJRSA42 .
